Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens epsilon prototoxin

Henry Hirschberg, Michelle J. Zhang, H. Michael Gach, Francisco A Uzal, Qian Peng, Chung Ho Sun, David Chighvinadze, Steen J. Madsen

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Cells infiltrating into normal brain from malignant brain tumors are protected by the blood brain barrier (BBB) which prevents the delivery and limits the effects of anti-tumor agents. We have evaluated the ability of photochemical internalization (PCI) to limit the effects of an agent known to broadly open the BBB to a target region of the brain. The PCI-based relocation and activation of macromolecules into the cell cytosol has the advantage of minimal side effects since the effect is localized to the area exposed to light, allowing the access of chemotherapeutic agents only to these regions. Non tumor bearing inbred Fisher rats were treated with photosesitizer, and a nontoxic intraperitoneal dose of Clostridium perfringens epsilon prototoxin (ETXp) followed by light exposure. Post-contrast T1 MRI scans were used to monitor the degree BBB disruption. F98 tumor cells were implanted into the brains of other animals that were subsequently treated 24 h later with ETXp-PCI BBB opening followed by the i.p. administration of bleomycin (BLM). PCI delivery of ETXp at low fluence levels demonstrated significant MRI enhancement. No effect on the BBB was observed if photosesitizer and light was given in the absence ETXp. The survival of animals implanted with F98 tumor cells was significantly extended following ETXp-PCI BBB opening and BLM therapy compared to controls. PCI delivered ETXp was effective in opening the BBB in a limited region of the brain. ETXp-PCI mediated BBB opening clearly increased the efficacy of BLM therapy.

Original languageEnglish (US)
Pages (from-to)317-329
Number of pages13
JournalJournal of Neuro-Oncology
Volume95
Issue number3
DOIs
StatePublished - Dec 2009

Fingerprint

Clostridium perfringens
Bleomycin
Blood-Brain Barrier
Brain
Light
Neoplasms
Brain Neoplasms
Cytosol
Magnetic Resonance Imaging
Therapeutics

Keywords

  • Bleomycin
  • Blood brain barrier
  • Brain tumor
  • Clostridium perfringens prototoxin
  • PDT
  • Photochemical internalization
  • Targeted opening

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neurology

Cite this

Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens epsilon prototoxin. / Hirschberg, Henry; Zhang, Michelle J.; Gach, H. Michael; Uzal, Francisco A; Peng, Qian; Sun, Chung Ho; Chighvinadze, David; Madsen, Steen J.

In: Journal of Neuro-Oncology, Vol. 95, No. 3, 12.2009, p. 317-329.

Research output: Contribution to journalArticle

Hirschberg, Henry ; Zhang, Michelle J. ; Gach, H. Michael ; Uzal, Francisco A ; Peng, Qian ; Sun, Chung Ho ; Chighvinadze, David ; Madsen, Steen J. / Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens epsilon prototoxin. In: Journal of Neuro-Oncology. 2009 ; Vol. 95, No. 3. pp. 317-329.
@article{128ea20ab6ef433c84d47db3ad0d589a,
title = "Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens epsilon prototoxin",
abstract = "Cells infiltrating into normal brain from malignant brain tumors are protected by the blood brain barrier (BBB) which prevents the delivery and limits the effects of anti-tumor agents. We have evaluated the ability of photochemical internalization (PCI) to limit the effects of an agent known to broadly open the BBB to a target region of the brain. The PCI-based relocation and activation of macromolecules into the cell cytosol has the advantage of minimal side effects since the effect is localized to the area exposed to light, allowing the access of chemotherapeutic agents only to these regions. Non tumor bearing inbred Fisher rats were treated with photosesitizer, and a nontoxic intraperitoneal dose of Clostridium perfringens epsilon prototoxin (ETXp) followed by light exposure. Post-contrast T1 MRI scans were used to monitor the degree BBB disruption. F98 tumor cells were implanted into the brains of other animals that were subsequently treated 24 h later with ETXp-PCI BBB opening followed by the i.p. administration of bleomycin (BLM). PCI delivery of ETXp at low fluence levels demonstrated significant MRI enhancement. No effect on the BBB was observed if photosesitizer and light was given in the absence ETXp. The survival of animals implanted with F98 tumor cells was significantly extended following ETXp-PCI BBB opening and BLM therapy compared to controls. PCI delivered ETXp was effective in opening the BBB in a limited region of the brain. ETXp-PCI mediated BBB opening clearly increased the efficacy of BLM therapy.",
keywords = "Bleomycin, Blood brain barrier, Brain tumor, Clostridium perfringens prototoxin, PDT, Photochemical internalization, Targeted opening",
author = "Henry Hirschberg and Zhang, {Michelle J.} and Gach, {H. Michael} and Uzal, {Francisco A} and Qian Peng and Sun, {Chung Ho} and David Chighvinadze and Madsen, {Steen J.}",
year = "2009",
month = "12",
doi = "10.1007/s11060-009-9930-4",
language = "English (US)",
volume = "95",
pages = "317--329",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "3",

}

TY - JOUR

T1 - Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens epsilon prototoxin

AU - Hirschberg, Henry

AU - Zhang, Michelle J.

AU - Gach, H. Michael

AU - Uzal, Francisco A

AU - Peng, Qian

AU - Sun, Chung Ho

AU - Chighvinadze, David

AU - Madsen, Steen J.

PY - 2009/12

Y1 - 2009/12

N2 - Cells infiltrating into normal brain from malignant brain tumors are protected by the blood brain barrier (BBB) which prevents the delivery and limits the effects of anti-tumor agents. We have evaluated the ability of photochemical internalization (PCI) to limit the effects of an agent known to broadly open the BBB to a target region of the brain. The PCI-based relocation and activation of macromolecules into the cell cytosol has the advantage of minimal side effects since the effect is localized to the area exposed to light, allowing the access of chemotherapeutic agents only to these regions. Non tumor bearing inbred Fisher rats were treated with photosesitizer, and a nontoxic intraperitoneal dose of Clostridium perfringens epsilon prototoxin (ETXp) followed by light exposure. Post-contrast T1 MRI scans were used to monitor the degree BBB disruption. F98 tumor cells were implanted into the brains of other animals that were subsequently treated 24 h later with ETXp-PCI BBB opening followed by the i.p. administration of bleomycin (BLM). PCI delivery of ETXp at low fluence levels demonstrated significant MRI enhancement. No effect on the BBB was observed if photosesitizer and light was given in the absence ETXp. The survival of animals implanted with F98 tumor cells was significantly extended following ETXp-PCI BBB opening and BLM therapy compared to controls. PCI delivered ETXp was effective in opening the BBB in a limited region of the brain. ETXp-PCI mediated BBB opening clearly increased the efficacy of BLM therapy.

AB - Cells infiltrating into normal brain from malignant brain tumors are protected by the blood brain barrier (BBB) which prevents the delivery and limits the effects of anti-tumor agents. We have evaluated the ability of photochemical internalization (PCI) to limit the effects of an agent known to broadly open the BBB to a target region of the brain. The PCI-based relocation and activation of macromolecules into the cell cytosol has the advantage of minimal side effects since the effect is localized to the area exposed to light, allowing the access of chemotherapeutic agents only to these regions. Non tumor bearing inbred Fisher rats were treated with photosesitizer, and a nontoxic intraperitoneal dose of Clostridium perfringens epsilon prototoxin (ETXp) followed by light exposure. Post-contrast T1 MRI scans were used to monitor the degree BBB disruption. F98 tumor cells were implanted into the brains of other animals that were subsequently treated 24 h later with ETXp-PCI BBB opening followed by the i.p. administration of bleomycin (BLM). PCI delivery of ETXp at low fluence levels demonstrated significant MRI enhancement. No effect on the BBB was observed if photosesitizer and light was given in the absence ETXp. The survival of animals implanted with F98 tumor cells was significantly extended following ETXp-PCI BBB opening and BLM therapy compared to controls. PCI delivered ETXp was effective in opening the BBB in a limited region of the brain. ETXp-PCI mediated BBB opening clearly increased the efficacy of BLM therapy.

KW - Bleomycin

KW - Blood brain barrier

KW - Brain tumor

KW - Clostridium perfringens prototoxin

KW - PDT

KW - Photochemical internalization

KW - Targeted opening

UR - http://www.scopus.com/inward/record.url?scp=70450233712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70450233712&partnerID=8YFLogxK

U2 - 10.1007/s11060-009-9930-4

DO - 10.1007/s11060-009-9930-4

M3 - Article

C2 - 19506813

AN - SCOPUS:70450233712

VL - 95

SP - 317

EP - 329

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 3

ER -